ACT-709478: Clinical Trials

1 trial of ACT-709478, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow ACT-709478: new trials by email Literature Review of ACT-709478 trials Research Report on ACT-709478

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients
ACT-709478 for oral use, Placebo - Photosensitive Epilepsy
Phase 2CompletedIdorsia Pharmaceuticals Ltd.52017-10-062018-08-31

Conditions studied

Epilepsy, Reflex (1)

Sponsors

Idorsia Pharmaceuticals Ltd. (1)

Countries

France (1)  ·  Germany (1)